Literature DB >> 28069535

Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.

Grazia Chiellini1, Lorenza Bellusci2, Martina Sabatini2, Riccardo Zucchi2.   

Abstract

Thyronamines are a novel class of endogenous signaling compounds, structurally related to thyroid hormones (THs). Specific thyronamines, particularly 3-iodothyronamine (T1AM), stimulate with nanomolar affinity trace amine-associated receptor 1 (TAAR1), a G protein-coupled membrane receptor, and may also interact with other TAAR subtypes (particularly TAAR5), adrenergic receptors (particularly α2 receptors), amine transporters, and mitochondrial proteins. In addition to its structural similarities with THs, T1AM also contains the arylethylamine scaffold as in monoamine neurotransmitters, implicating an intriguing role for T1AM as both a neuromodulator and a hormone-like molecule constituting a part of thyroid hormone signaling. A large number of T1AM derivatives have already been synthesized. We discuss the different chemical strategies followed to obtain thyronamine analogues, their potency at TAAR1, and their structure-activity relationship. Preliminary characterization of the functional effects of these synthetic compounds is also provided.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adrenergic receptors; Thyronamine-like compounds; Thyronamines; Trace amine-associated receptors

Mesh:

Substances:

Year:  2017        PMID: 28069535     DOI: 10.1016/j.mce.2017.01.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  Novel thyroid hormones.

Authors:  Riccardo Zucchi; Grazia Rutigliano; Federica Saponaro
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

Review 2.  The relation between thyroid dysregulation and impaired cognition/behaviour: An integrative review.

Authors:  Manizhe Eslami-Amirabadi; Seyed Ahmad Sajjadi
Journal:  J Neuroendocrinol       Date:  2021-03       Impact factor: 3.627

3.  New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.

Authors:  Lorenza Bellusci; Annunziatina Laurino; Martina Sabatini; Simona Sestito; Paola Lenzi; Laura Raimondi; Simona Rapposelli; Francesca Biagioni; Francesco Fornai; Alessandra Salvetti; Leonardo Rossi; Riccardo Zucchi; Grazia Chiellini
Journal:  Front Pharmacol       Date:  2017-12-12       Impact factor: 5.810

Review 4.  Torpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?

Authors:  Hartmut H Glossmann; Oliver M D Lutz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-31       Impact factor: 5.555

5.  Metabolic Reprogramming in Health and Disease.

Authors:  Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2020-04-16       Impact factor: 5.923

Review 6.  The Case for TAAR1 as a Modulator of Central Nervous System Function.

Authors:  Grazia Rutigliano; Alice Accorroni; Riccardo Zucchi
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

7.  Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.

Authors:  Xiaoqun Zhang; Ioannis Mantas; Alexandra Alvarsson; Takashi Yoshitake; Mohammadreza Shariatgorji; Marcela Pereira; Anna Nilsson; Jan Kehr; Per E Andrén; Mark J Millan; Karima Chergui; Per Svenningsson
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

8.  Thyroid Hormone Analogues: An Update.

Authors:  Riccardo Zucchi
Journal:  Thyroid       Date:  2020-04-07       Impact factor: 6.568

9.  Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents Through the Modulation of SIRT6.

Authors:  Lorenza Bellusci; Massimiliano Runfola; Vittoria Carnicelli; Simona Sestito; Federica Fulceri; Filippo Santucci; Paola Lenzi; Francesco Fornai; Simona Rapposelli; Nicola Origlia; Riccardo Zucchi; Grazia Chiellini
Journal:  Molecules       Date:  2020-02-26       Impact factor: 4.411

Review 10.  3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?

Authors:  Grazia Rutigliano; Lavinia Bandini; Simona Sestito; Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2020-03-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.